These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Failure of lidocaine to suppress lethal ischemic ventricular arrhythmias in a canine model of previous myocardial infarction. Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Stein RB J Cardiovasc Pharmacol; 1990 Jul; 16(1):41-9. PubMed ID: 1696665 [TBL] [Abstract][Full Text] [Related]
4. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide. Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233 [TBL] [Abstract][Full Text] [Related]
5. Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation. Uprichard AC; Allen JD; Harron DW J Cardiovasc Pharmacol; 1988 Feb; 11(2):235-41. PubMed ID: 2452320 [TBL] [Abstract][Full Text] [Related]
6. Prophylaxis of primary ventricular fibrillation with tocainide in acute myocardial infarction. Campbell RW; Hutton I; Elton RA; Goodfellow RM; Taylor E Br Heart J; 1983 Jun; 49(6):557-63. PubMed ID: 6405764 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction. Wallace AA; Stupienski RF; Kothstein T; Gehret JR; Lynch JJ J Cardiovasc Pharmacol; 1993 Mar; 21(3):397-404. PubMed ID: 7681500 [TBL] [Abstract][Full Text] [Related]
8. Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction. Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR Pharmacology; 1987; 35(4):181-93. PubMed ID: 3118399 [TBL] [Abstract][Full Text] [Related]
9. Tocainide: a new oral antiarrhythmic. Hasegawa GR Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. Hellestrand KJ Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822 [No Abstract] [Full Text] [Related]
11. Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarction. Rehnqvist N; Erhardt L; Ericsson CG; Olsson G; Svensson G; Sjögren A Acta Med Scand; 1983; 214(1):21-7. PubMed ID: 6414252 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. Reiter MJ; Easley AR; Mann DE Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228 [TBL] [Abstract][Full Text] [Related]
13. Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death. Kou WH; Nelson SD; Lynch JJ; Montgomery DG; DiCarlo L; Lucchesi BR J Am Coll Cardiol; 1987 Feb; 9(2):359-65. PubMed ID: 3100599 [TBL] [Abstract][Full Text] [Related]
14. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction. Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937 [TBL] [Abstract][Full Text] [Related]
15. Tocainide and mortality after myocardial infarction: a prospective study in conscious dogs. Vanoli E; Hull SS; Stith RD; Adamson PB; Foreman RD; Schwartz PJ J Am Coll Cardiol; 1990 Nov; 16(6):1475-80. PubMed ID: 2121814 [TBL] [Abstract][Full Text] [Related]
16. Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs. Krejcy K; Krumpl G; Todt H; Raberger G Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):213-8. PubMed ID: 1448183 [TBL] [Abstract][Full Text] [Related]
17. Selective effects of tocainide in canine acute myocardial infarction. Hiromasa S; Li ZY; Coto H; Maldonado C; Kupersmith J Int J Cardiol; 1990 Apr; 27(1):79-86. PubMed ID: 2110552 [TBL] [Abstract][Full Text] [Related]
18. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165. Hashimoto K; Ishii M; Komori S; Mitsuhashi H Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304 [TBL] [Abstract][Full Text] [Related]
19. Tocainide. A review of its pharmacological properties and therapeutic efficacy. Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic actions of pirmenol in dogs with recent myocardial infarction. Lynch JJ; DiCarlo LA; Montgomery DG; Hassan T; Lucchesi BR Am Heart J; 1986 Oct; 112(4):752-8. PubMed ID: 3766375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]